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Abstract
Background: The MODEM project (A comprehensive approach to MODelling outcome and costs impacts of
interventions for DEMentia) explores how changes in arrangements for the future treatment and care of people
living with dementia, and support for family and other unpaid carers, could result in better outcomes and more
efficient use of resources.
Methods: MODEM starts with a systematic mapping of the literature on effective and (potentially) cost-effective
interventions in dementia care. Those findings, as well as data from a cohort, will then be used to model the
quality of life and cost impacts of making these evidence-based interventions more widely available in England
over the period from now to 2040. Modelling will use a suite of models, combining microsimulation and
macrosimulation methods, modelling the costs and outcomes of care, both for an individual over the life-course
from the point of dementia diagnosis, and for individuals and England as a whole in a particular year.
Project outputs will include an online Dementia Evidence Toolkit, making evidence summaries and a literature
database available free to anyone, papers in academic journals and other written outputs, and a MODEM Legacy
Model, which will enable local commissioners of services to apply the model to their own populations.
Discussion: Modelling the effects of evidence-based cost-effective interventions and making this information
widely available has the potential to improve the health and quality of life both of people with dementia and their
carers, while ensuring that resources are used efficiently.
Keywords: Dementia, Costs, Outcomes, Treatments, Social care, Carers, Microsimulation model, Economics,
Cost-effectiveness
Background
There are currently around 835,000 people in the United
Kingdom (UK) who have dementia [1], and an estimated
670,000 unpaid dementia carers, most of them family
members [2]. If current rates of prevalence of dementia
by age and gender remain unchanged, this number will
grow to more than 1 million by 2021 and 2 million by
2051 as a consequence of population ageing [1]. Even if
prevalence rates are declining slightly, as some recent
studies suggest [3, 4] the numbers of people living with
dementia will still increase nationally and globally, where
it is projected that the number will grow from 46.8
million people today, to 131.5 million in 2050 [5].
If service models remain unchanged, the costs of treat-
ment and care for people with dementia are likely to
increase more rapidly than total prevalence over the
same period, since care services are highly labour-
intensive and wage inflation usually runs ahead of other
price increases. This will put considerable pressure on
already stretched health and social care budgets and
generate major increases in reliance on family carers.
(We use the term ‘family carers’ in preference to ‘unpaid’
* Correspondence: a.comas@lse.ac.uk
1Personal Social Services Research Unit, London School of Economics and
Political Science, London, UK
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Comas-Herrera et al. BMC Health Services Research  (2017) 17:25 
DOI 10.1186/s12913-016-1945-x
or ‘informal’ carers as neither of the latter terms is
fully accurate; most carers of people with dementia in
England are family members and our reference group
have expressed a preference for this term.)
The MODEM project (A comprehensive approach to
MODelling outcome and costs impacts of interventions
for DEMentia) explores how changes in arrangements
for the future treatment and care of people with demen-
tia, and support for carers, could result in better out-
comes and more efficient use of resources. To do this,
the MODEM team is reviewing international evidence
on effective and (potentially) cost-effective interventions
in dementia care, and then using those findings, with
analyses of existing and new cohort data, to model the
quality of life and cost impacts of making these interven-
tions more widely available in England over the period
from now to 2040. The MODEM project began in 2014
and runs until February 2018. It is funded by the UK
Economic and Social Research Council (ESRC) and the
National Institute for Health Research (NIHR).
Conceptual framework
Conceptually, the project is rooted in the ‘disablement
process’ model and the ‘production of welfare’ framework.
The ‘disablement process’ model, proposed by Verbrugge
and Jette [6], builds on previous models developed by
the World Health Organization (WHO) and others. It
conceptualises the ways in which needs for long‐term
care arise (from pathology to impairments in specific
body systems which lead to restrictions in basic phys-
ical and mental actions, and finally to disability), as well
as how and at what stages individual risk factors and
environmental factors might influence this process.
Similarly, the International Classification of Functioning,
Disability and Health (ICF) describes decreases in function
as the complex and dynamic interaction of health condi-
tions (pathology) with extra- and intra-individual factors
acting to mitigate or exacerbate the process [7]. However,
where the endpoint of the Verbrugge and Jette model was
disablement, the ICF outline includes participation in
society as the ultimate goal to attain. In addition, the more
linear pathway from disease to disability in the Verbrugge
and Jette model has been loosened.
At each stage of the disablement process (in this
model) there are potential opportunities to halt or even
reverse the process. These include altering individual
risk factors for chronic conditions (e.g. through changes
in lifestyle, such as smoking and exercise) or imple-
menting improvements in the management of chronic
conditions. The consequences of functional limitations
associated with disability can also sometimes be reduced
through aids and adaptations, information and com-
munication technology, occupational therapy, suitable
housing or relevant changes in the wider environment.
Once needs have emerged, we use the ‘production of
welfare’ framework [8, 9] to capture the potential rela-
tionships between needs, resources and outcomes. This
framework has underpinned much of the work of the
Personal Social Services Research Unit (PSSRU) in social
care, mental health and other areas over a 40-year
period. The framework represents a simplification of the
multifarious links between budgets, staff and other
‘inputs’ (and their associated costs), the services that are
produced, the ‘non-resource’ influences on what services
can achieve (such as personal resilience and staff
attitudes) and the health and wellbeing outcomes that
potentially result for people with dementia, their families
and relevant others.
Project aims and objectives
The MODEM project aims to generate new evidence to
inform policy and practice to better and more efficiently
meet needs, promote health and wellbeing for people
with dementia and their family and other carers.
The project objectives are to:
1. Build a comprehensive conceptual, integrated
framework that covers impacts of dementia on
cognition, functioning and behaviour, responses
from carers, responses from health and social care
systems, the effectiveness and resource impacts of
these interventions, and the potential long-term
funding implications;
2. Develop a suite of linked quantitative models,
employing both microsimulation and
macrosimulation techniques, to project future
numbers of people with dementia, their dependency
and other needs, comorbidities, levels of unpaid and
formal care and associated expenditure;
3. To estimate typical life-time costs of dementia,
under varying assumptions about risk factors,
patterns of care and support, and preferences;
4. Review the literature for evidence on interventions
that could delay onset, slow deterioration in cognition,
functioning or behaviour, or reduce their adverse
impacts on health wellbeing, both for people with
dementia and carers, and also evidence on costs;
5. Gather evidence on the lives of people with
dementia and their carers by collecting primary data
from a new cohort, by conducting qualitative
interviews and focus groups, and by examining data
from previous trials and observational studies;
6. Use the evidence from objectives 4 and 5, in
combination with the micro- and macro-simulation
models, to produce projections to 2040 of the
numbers of older people with dementia in England,
their needs for care and support, and associated
public and private expenditure, together with
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projected outcomes and costs of a range of interven-
tions to prevent or delay dementia incidence, slow
symptom development, provide treatment and care,
and support carers;
7. Develop a Dementia Evidence Toolkit to make available
evidence summaries of the effectiveness and
cost-effectiveness of dementia care and treatment
interventions and a searchable bibliographic
database; and
8. Develop a publicly available web-tool (MODEM
Legacy Model) to enable service commissioners,
providers, advocacy groups, individuals and families
to access the findings and outputs of the project,
and to make their own projections of expected
needs for care and support, outcomes and costs.
Methods
Over-arching research strategy
We first provide an over-arching summary of the inter-
connected activities of the project, and then describe
each of the main elements in more detail.
We are engaging with people living with dementia,
carers and others at all stages of the project. We are
starting by examining extant data to understand the links
between the characteristics of individuals and families,
their dementia-related and other needs for care and
support, and the services and treatments that could be
available to them. We are then looking at the effects of
care, support and treatments on outcomes for individuals
and carers - how those interventions can improve their
health and wellbeing - and also on the costs of support.
We will use this information, as well as specially
collected data from a cohort, to make projections of
how many people there will be with dementia in England
over the period to 2040, the family or other unpaid
support they are likely to have available, and the costs to
provide care services for them. Second, we are examining
whether there are better ways to support people with
dementia and their carers by making evidence-based
forms of care and treatment more widely available. We
are relying on previous evaluations of these interventions
to demonstrate the effects on health and wellbeing, and
on costs. We are potentially including a wide set of inter-
ventions, including medication, cognitive stimulation and
other therapies, exercise programmes, nutrition advice,
telecare, case management, community initiatives, respite
and training for carers.
We are also collecting primary data from a new cohort
300 people with dementia and their carers at two points
of time, 12 months apart. We are not testing any inter-
ventions with these people; rather, we are collecting
information to allow an analysis of the relationship
between measures (i.e. ‘cross-walking’) and to fill gaps
in available evidence. We are additionally conducting
qualitative interviews and focus groups to gain further
‘experiential’ evidence.
A range of quantitative methods will be used, includ-
ing dynamic micro-simulation projection modelling, to
understand the disabling consequences of dementia, and
a series of care pathways models to show how evidence-
based interventions can influence outcomes, service use
and costs. A life-time costs model will generate esti-
mates of the overall costs of the care pathway for each
intervention, and a macro-simulation projection model
will generate estimates of long-term care needs and
costs to 2040.
Our final task will be to create a ‘MODEM legacy
model’ to allow commissioners, providers, individuals
and advocacy groups to make their own projections of
needs, outcomes and costs using our estimates.
Involving people with dementia, carers and other
stakeholders
The project benefits from the regular input of key stake-
holders, including members of our overarching Advisory
Group, our Reference Group of people with dementia,
carers and service providers, and our Impact Advisory
Group (chief executives and public policy leads). The
research team is building on existing links with key
central government departments in England (e.g. Health,
Communities and Local Government, Work and Pensions,
and Treasury), third sector organisations (e.g. Alzheimer’s
Society, Alzheimer’s Research UK, Carers UK), National
Health Service (NHS) England and Public Health England,
and local councils and their umbrella bodies (the
Association of Directors of Adult Social Services, Local
Government Association).
Mapping the literature and conducting evidence reviews
A systematic mapping of relevant literature will be
conducted with the aim of identifying interventions that
can prevent or delay dementia onset, reduce symptom
severity and/or improve quality of life of people with
dementia and/or family and other carers.
We are first identifying previously published system-
atic reviews and meta‐analyses and then searching for
papers that have not been included in previous system-
atic reviews (for example, because they have been
published more recently). We will also identify relevant
literature in areas that have not been covered by previ-
ous reviews, carrying out our own new reviews where
there are gaps.
Our careful consideration of the available evidence will
inform the selection of interventions to be modelled
later in the project.
The review of evidence should be of value in its own
right as it will identify areas in which there is strong
existing evidence, as well as where there has been little
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research undertaken and interventions for which there is
insufficient evidence. Some of the outputs from the
evidence review, a coded bibliographic database and a set
of evidence summaries written in non-technical language,
will be made publicly available through a website, the
Dementia Evidence Toolkit, so that people with dementia,
carers, care providers, commissioners, researchers and
others can access the resources.
It is expected that the review process will also draw
out the implications of using different research methods
for the usability of evidence in modelling and in
commissioning.
Modelling future numbers of people with dementia and
their carers, costs and outcomes
The core of the project involves the development of a
suite of linked quantitative models, using micro‐ and
macro‐simulation, to project future numbers of people
with dementia, unpaid and formal care and associated
expenditure, and to estimate typical life‐time costs of
dementia. The projections will be based on assumptions
about risk factors, patterns of care and support, and
individual preferences.
Macrosimulation model
We are developing a macro-simulation model to pro-
duce overall projections of future numbers of people
with dementia and future expenditures on their treat-
ment and care. It will take as inputs the outputs of the
microsimulation and interventions models described
below. This model builds on previous cognitive impair-
ment and long-term care models developed at PSSRU
[10, 11]. It projects future use of care and associated
costs and quality of life of people with dementia
and carers.
A key feature of this new model is that it will differen-
tiate between groups of people with dementia by severity
of cognitive impairment and physical disability, and it
will ‘assign’ packages of care to people with dementia
based on their characteristics including severity of
condition and comorbidities. The model will use data
from the latest MRC Cognitive Function and Ageing
Study (CFAS II) [12], the English Longitudinal Study of
Ageing (ELSA) [13], official data from the Health and
Social Care Information Centre, the baseline data of
various trials of interventions for people with dementia
(see below) and new data collected as part of this study
(the cohort study described above).
Microsimulation epidemiological model
A micro-simulation population model (MicSIMPOP) is
being developed to examine the health and associated
care needs of the English population over the coming
decades, and the impact of interventions for risk factor
reduction, disease prevention and treatments that slow
down progression to disease (including dementia) and
disability. This is a more comprehensive, up-to-date
version of a previous macro-simulation population model
(SIMPOP) [14].
The model will be based on longitudinal data from
Understanding Society (adults 35 years and over in com-
munity dwellings [15]), ELSA (adults aged 50 years and
over in community dwellings) and the new CFAS II
cohort (adults 65 years and over, including those in insti-
tutions). These three datasets, suitably weighted, will
allow inferences to be made for the older English popu-
lation (65 years and over) to 2040. Baseline charac-
teristics generated on these individuals will be of three
types: socio-demographic (differentiated by the following
variables: age, gender, living arrangements, marital sta-
tus, education, retirement status); lifestyle behaviours
(smoking, alcohol consumption, physical activity, body
mass index, social engagement); and diseases (cognitive
impairment/dementia, coronary heart disease, stroke,
hypertension, diabetes, respiratory disease, arthritis, can-
cer) as well as geriatric conditions (hearing and vision
impairment). Mortality rates from the most recent popu-
lation projections will be applied by age and gender. The
outcome variable will be disability measured by the
interval of need scale [16], which categorises people on
the basis of Activities of Daily Living/Instrumental
Activities of Daily Living in terms of the intensity of
care required.
The primary output will be tabulations of disability by
age and gender in the presence of cognitive impairment/
dementia and any other diseases which will be used as
inputs to the macro-simulation framework model de-
scribed earlier. The issue of co-morbidity will become
crucial when determining the types of care packages
required, and their cost. For other conditions, known
trends in disease risk factor prevalence will be incorpo-
rated, such as smoking and obesity, as well as changes in
socio-demographic variables (education, marital status,
living circumstances). We will use bootstrapping to pro-
vide measures of uncertainty around estimates; the work
will also include individual biographies to feed into the
life-time costs model as well as calculation of disability-
free life expectancy to allow exploration of the likelihood
of compression or expansion of disability given different
health scenarios.
Intervention modelling
The impact of interventions in dementia care, particu-
larly the impacts on costs and outcomes of care for
particular groups of people with dementia and for
their family and other carers, will be modelled using
intervention-specific models. The degree of sophistica-
tion of the models will vary depending on the nature
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of the impacts of different interventions and the type
of evidence available on them. We envisage that some
of the models may be simple decision models, while
we expect to be able to carry out microsimulation analyses
for other interventions. The outcomes of interventions
modelling will be integrated into the macro-simulation
model to produce national-level projections of changes in
costs and quality of life arising from their wider adoption.
We will model only one intervention at a time, except
in cases where we have evidence of combinations of
interventions being evaluated together, such as main-
tenance cognitive stimulation therapy and donezepil
[17, 18]. This is because we are not able to assess the
‘additive’ impact of different interventions unless they
have already been evaluated in combination.
The choice of interventions included in this modelling
will be influenced by what we find from our evidence
reviews (described earlier), by what data we can access
(either directly on those interventions or by parameter
estimation in simulation models) and by the views of
experts in the field.
Lifetime model
We are also developing a ‘lifetime’ model to examine the
individual costs of dementia over a lifetime, and the
impact on quality of life. This model considers the aver-
age duration of dementia from onset (i.e. the time at
which it could first be diagnosed) to end of life. This
duration is divided between periods of mild, moderate
and severe dementia, and between residence in the com-
munity and in a care home. Costs of care appropriate to
the severity of cognitive impairment and the type of care
are attached to each month of the dementia pathway,
and costs are then aggregated over the whole duration
with dementia.
Data sources
As there is no single dataset that has all the data we
need for the modelling, we will bring together data from
a variety of sources. As we have already described, the
epidemiological model will draw upon data from three
major longitudinal studies: Understanding Society, ELSA
and CFAS II, this being the first time that these three
studies have been combined. We also use data from
ELSA and the Health Survey of England (HSE) to
complement the information on use of care services and
unpaid care at national level.
For our intervention models, we will carry out detailed
modelling of the impact of interventions on costs and
outcomes using individual-level baseline or ‘usual care’
group data from a number of recently completed or
ongoing dementia trials in the UK (details available on
request). In this way we can understand the relation-
ships between particular patterns of needs (e.g. cognitive
impairment, behaviour, functional disability), individual
characteristics (e.g. age, gender, co‐morbidities) and
circumstances (e.g. living alone, socioeconomic status) of
the person with dementia and their carers.
Primary data collection
Since our models will combine data from various popu-
lation surveys, clinical trials and observational studies,
we need to be able to combine and compare different
measures of the same underlying domains (e.g. cogni-
tion, carer impact or quality of life). We are able to use
trial’ data to explore associations between two or more
different measures of the same domain, but these only
provide some of the information we need. We are there-
fore collecting primary data from a cohort of people
with dementia and carers.
In face-to-face interviews, we ask 300 dyads of people
with a diagnosis of dementia and their carers to complete
a selection of overlapping measures of need, care use and
outcomes. Analysis of the resulting data enables us to
‘cross-walk’ between the different measures and studies.
In addition the dataset will provide valuable information
in its own right. For example, we use an adapted version
of the Client Service Receipt Inventory (CSRI) [19] so that,
as well as gathering information on use of services by
people with dementia and support from family and
other carers, evidence can be built up on some key
associations (such as carer age and gender, and their
links to carer wellbeing).
Individuals included in this cohort study have been
identified from the clinical populations served by the
Sussex Partnership NHS Foundation Trust with sup-
port for recruitment through the Join Dementia Re-
search initiative funded by the Department of Health
and delivered in partnership with the National Institute
for Health Research, Alzheimer Scotland, Alzheimer’s
Research UK and the Alzheimer’s Society. Participants
are drawn from East and West Sussex and Brighton
and Hove, a population of 500,000 older adults, which
includes an estimated 30,000 people with dementia;
similar to the national population except with respect
to deprivation and ethnicity (although it is unlikely this
will have a major bearing on the cross-walking of pa-
rameters). People with dementia involved in the study
all have a clinical diagnosis of dementia, established
using ICD‐10 criteria. The cohort is being stratified by
dementia severity, with 100 people with mild dementia
(i.e. scoring 20+ on the standardised Mini‐Mental State
Examination (sMMSE) [20]), 100 people with moderate
dementia (scoring 10–19) and 100 people with severe
dementia (scoring 0–9). A sample of 300 subjects gives
sufficient precision to generate the insights we need
into relationships between variables.
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People with dementia and their carers are being inter-
viewed at baseline and 52 weeks later in either the clinic
that they usually attend or in their own home. Interviews
are designed to minimise respondent burden while still
collecting comprehensive data. Data collection is split
between people with dementia and carers, who are inter-
viewed simultaneously by researchers operating in pairs.
Individuals are sent a written invitation to take part in the
study by their clinical team; this is followed up by tele-
phone contact to arrange a home or clinic visit. At the
first meeting the researchers assess capacity and obtain
appropriate consents; if consent is given, the people with
dementia and their main family carer are interviewed.
Analysing relationships between characteristics, needs,
resources and outcomes
A key part of the project involves gaining a better under-
standing of the relationship between the individual
characteristics and circumstances of both people with
dementia and unpaid carers, their needs, resources, and
how these relationships are likely to affect the outcomes
of interventions. We are using both quantitative and
qualitative methods to understand these relationships,
which will provide the key parameters for the models.
We are focussing in particular on the following areas.
Relationships between personal characteristics, need
factors, use of paid and unpaid care and quality of
life Using as a framework the ‘production of welfare’
approach, we are analysing a number of datasets to
understand better the relationships between personal
characteristics such as age, gender, household type, edu-
cation, severity and type of care needs, the use of family
and paid care, and the quality of life of people with
dementia and their carers. Multivariate analyses will
provide us with parameters that will be used in the
simulation models (see above).
Social interaction and participation over the life‐course
Factors associated with cognitive ability and dementia
include age, gender, education, socioeconomic status,
and smoking [21]. There is also growing awareness of
the protective or buffering effect of social participation,
while indicators of social isolation are risk factors for
cognitive decline [22, 23]. This may reflect both effects
of social interaction on cognition and effects of social
resources on coping strategies adopted in the face of
impairment, as proposed in the theoretical models of
selection, optimisation and compensation [24]. As chil-
dren are an important source of social support for older
people, we have investigated whether fertility histories
are associated with social participation and with cogni-
tive function in later life [25]. Results suggest disadvan-
tages for childless older people, even after taking into
account socio-economic status, health-related behav-
iours and social contacts. We are undertaking further
work on possible direct or indirect effects of long-term
social interaction on cognitive functioning in early
and later old age. We are also examining the effect of
accumulated social support networks on formal help-
seeking and receipt of services, among those with
cognitive impairment.
‘Cognitive reserve’ is a widely used construct to
explain how, in the face of neurodegenerative changes
similar in nature and extent, individuals vary in their
severity of cognitive ageing and clinical dementia [26].
People with high reserves may have increased capacity
for continued learning and adaptation, despite age-
related changes. Data on cognitive functioning are taken
from the National Child Development Study (NCDS)
and ELSA [27]; both used the same measure at key
waves (age 50 for NCDS (and educational performance
indicators up to age 16); ages 50 and above from Waves
1–5 of ELSA). They also include measures of social
networks, support and, in the case of ELSA, service use.
Social interaction is defined in terms of contacts with
social network members, and includes size, type, and
support; social participation is defined by engagement in
social and leisure activities, including physical activity.
The wellbeing of family carers: investigating gender
and relational differences A PhD studentship attached
to MODEM (held by KL) is investigating the influence
of age and gender on the wellbeing of male and female
family carers of people with dementia, distinguishing
those of the same and next generation. The two core
research questions are:
 Are there measurable differences in the wellbeing of
male and female family carers for people with
dementia of the same and next generation?
 Does the wellbeing of unpaid carers for people with
dementia differ from the general British population?
To answer this research question, data from three
sources will be pooled and analysed: the StrAtegies for
RelaTives study (START) [28], the Support at Home:
Interventions to Enhance Life in Dementia: Carer
Supporter Programme — Remembering Yesterday Car-
ing Today (SHIELD CSP RYCT) [29] and data from the
MODEM cohort described above. All three studies share
important variables on carer characteristics, standardised
measures for carer wellbeing, as well as some important
variables related to the person with dementia.
The second part of this PhD work focuses on the
qualitative aspects of how men and women of different
ages experience the provision of unpaid dementia care
and construct wellbeing. In-depth interviews are being
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conducted with participants of the MODEM cohort
study. Thematic analysis will be used to analyse the data.
The third part investigates the costs incurred by family
carers. For this an amended form of the Resource
Utilization in Dementia (RUD) instrument [30] is being
collected as part of the MODEM cohort study. The
study aims to analyse whether there are differences in
costs by gender and relationship to the care recipient.
Understanding the experiences of people with dementia
and their carers Interactive focus group settings will
provide opportunities for people with dementia and
family carers to discuss their attitudes, beliefs and expe-
riences with others. The discussions will be based on
issues emerging from the modelling and cohort survey,
with potential participants to be recruited through
voluntary sector organisations for people with dementia
and carers, and the team’s existing contacts. The
groups will help provide insights and understandings
for interpreting quantitative findings, including carers’ ex-
periences of the processes of accessing dementia‐related
services.
Group discussions have potential advantages over indi-
vidual interviews for people with cognitive impairments,
including enhanced quality of interaction, reduced pres-
sure on individuals to respond, mutual support, and that
shared experiences can trigger ideas and memories.
Using skilled facilitators with experience of working
with people with dementia has been found to be import-
ant, especially in giving prompts to move people on to
new areas of discussion and to avoid leading anyone
with answers.
We will set up four focus groups of eight people each
with dementia of mild severity, and four separate groups
of eight carers each (held at same venues, at the same
times), at key points within the project to aid interpret-
ation of modelling and quantitative analyses.
MODEM Legacy model
The final objective of the study is to develop a legacy
model, to enable stakeholders to access the findings and
outputs of the project, and make their own local projec-
tions of expected outcomes and costs by entering data
relevant to local needs. This will be publicly available on
the World Wide Web, and is aimed at service commis-
sioners, policy makers, providers, advocacy groups, and
individuals and families affected by dementia. It will
enable high-level planning of services and will allow
commissioners and providers to explore the implications
of demand for services and associated costs, based on
varying assumptions of prevalence rates of dementia in
the future and patterns of care. It will be user‐friendly,
with an easy‐to operate ‘front end’ and accessible user
guide. We will consult people with dementia, family
carers and representatives of the NHS, local authorities
and voluntary sector organisations in our planning of
the legacy model.
Discussion
Dementia has enormous impacts on the health and qual-
ity of life for people with the condition, their families
and other people who care for them. Many people with
dementia need care in many areas of their lives, and use
a range of health and social care services, as well as
getting support from their family carers. As the symp-
toms of dementia worsen, some people will need to
move into care homes. The costs of care and support
can therefore be high. As the English population ages
over the coming decades, so the number of people with
dementia will increase considerably. This poses a poten-
tially major challenge for health and care systems that
are already very stretched: how can we ensure a good
quality of life for people with dementia and their carers
at a cost that is considered by society to be affordable?
The MODEM project is using a range of interconnected
methods to feed new evidence into this national debate
about how to respond to the challenge of dementia. We
are developing a comprehensive, integrated set of quanti-
tative models to estimate current and future needs, and
the outcomes and costs of interventions aimed at meeting
them, taking into account the complexity of individuals’
lives. We are collecting rich qualitative data to help us
interpret the associations in those models. And we are
then simulating the impacts of interventions for which
there is robust or promising evidence from completed or
on-going trials or other studies.
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